Amphastar Pharmaceuticals, Inc.
AMPHDrug Manufacturers - Specialty & Generic
$27.72+2.93%As of Oct 30vs prior close
- Market cap
- $1.2B
- P/E (TTM)
- 15.9×
- P/E (FY1)
- 9.4×
- From 52W high
- −5.71%
- EPS (LTM)
- $1.69
- Revenue (LTM)
- $730M
- Net margin
- 10.76%
- Dividend yield
- 0.00%
Nomior Score
55
Kindling TurnSpeculativeTop 39% of the scored universe
Growth37
Quality59
Value80
Momentum46
Resilience46
Growth
+12.21%revenue a year over 9 fiscal years
YE16 $255.2MLTM $730M
Connections
Revenue to profitQ2 YE26
17% of revenue became net profit, down 1 pt on a year.
Who owns it
2funds